Beyond traditional treatments for Clostridium difficile disease (CDD): Saccharomyces boulardii.

被引：0
|
作者：
McFarland, LV
Melcher, SA
Surawicz, CM
Fekety, R
Greenberg, RN
Rubin, M
机构：
来源：
GASTROENTEROLOGY | 1996年 / 110卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A28 / A28
页数：1
相关论文
共 48 条
  • [41] RECURRENT CLOSTRIDIUM-DIFFICILE INFECTION IN A PATIENT WITH SELECTIVE IGG1 DEFICIENCY TREATED WITH INTRAVENOUS IMMUNE GLOBULIN AND SACCHAROMYCES-BOULARDII
    HASSETT, J
    MEYERS, S
    MCFARLAND, L
    MULLIGAN, ME
    CLINICAL INFECTIOUS DISEASES, 1995, 20 : S266 - S268
  • [42] Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters
    Koon, Hon Wai
    Su, Bowei
    Xu, Chunlan
    Mussatto, Caroline C.
    Diana Hoang-Ngoc Tran
    Lee, Elaine C.
    Ortiz, Christina
    Wang, Jiani
    Lee, Jung Eun
    Ho, Samantha
    Chen, Xinhua
    Kelly, Ciaran P.
    Pothoulakis, Charalabos
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2016, 311 (04): : G610 - G623
  • [43] Saccharomyces boulardii anti-inflammatorv factor inhibits MAPK activation in colonic epithelial cells and protects against clostridium difficile toxin A-induced enteritis
    Chen, XH
    Kokkotou, EG
    Mustafa, N
    Bhaskar, KR
    O'Brien, M
    Pothoulakis, C
    Kelly, CP
    GASTROENTEROLOGY, 2005, 128 (04) : A67 - A67
  • [44] Probiotic Saccharomyces boulardii CNCM I-745 Inhibits Hypervirulent Clostridium difficile-Associated Cecal Tissue Damage and Pro-Inflammatory Cytokine Expression in Hamsters
    Koon, Hon Wai
    Diana Hoang-Ngoc Tran
    Chen, Xinhua
    Kelly, Ciaran P.
    Pothoulakis, Charalabos
    GASTROENTEROLOGY, 2016, 150 (04) : S23 - S24
  • [45] Presence of anti-saccharomyces cerevisiae antibody in Clostridium difficile--associated diarrhoea is similar to that in crohn's disease
    Subramanian, V.
    Pollok, R.
    GUT, 2008, 57 : A149 - A149
  • [46] SACCHAROMYCES BOULARDII CNCM I-745 LOWERS FECAL CHOLIC ACID CONCENTRATIONS DURING ANTIBIOTHERAPY IN HEALTHY VOLUNTEERS: A NEW POTENTIAL MECHANISM IN THE PROTECTION AGAINST CLOSTRIDIUM DIFFICILE INFECTION
    Duboc, Henri
    Kabbani, Toufic
    Nguyen, Caroline Chong
    Pallav, Kumar
    Dowd, Scot E.
    Humbert, Lydie
    Seksik, Philippe
    Bado, Andre
    Coffin, Benoit
    Rainteau, Dominique
    Kelly, Ciaran P.
    GASTROENTEROLOGY, 2017, 152 (05) : S33 - S33
  • [47] Current Evidence in Delivery and Therapeutic Uses of Fecal Microbiota Transplantation in Human Diseases-Clostridium difficile Disease and Beyond
    Stripling, Joshua
    Rodriguez, Martin
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2018, 356 (05): : 424 - 432
  • [48] Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis
    Chen, Xinhua
    Kokkotou, Efi G.
    Mustafa, Nasima
    Bhaskar, K. Ramakrishnan
    Sougioultzis, Stavros
    O'Brien, Michael
    Pothoulakis, Charalabos
    Kelly, Ciaran P.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (34) : 24449 - 24454
12345